Seoul
South Korea
9
2026-06-11
7
2025-08-12
These are the the leading inventors for applications assigned to AUTOTAC INC.:
AUTOTAC INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANDROGEN RECEPTOR DEGRADERS FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER AND USE THEREOF
#2 | 2023-06-22 ✅ Patent 12,383,624 granted on 2025-08-12NOVEL CARGO DELIVERY SYSTEM AND COMPOSITION COMPRISING THE SAME
#3 | 2023-06-08 ✅ Patent 12,559,455 granted on 2026-02-24COMPOUND AS A UBR BOX DOMAIN LIGAND
#4 | 2023-06-08 ✅ Patent 12,509,420 granted on 2025-12-30COMPOUND AS A UBR BOX DOMAIN LIGAND
#5 | 2022-12-22NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
#6 | 2022-09-22 ✅ Patent 11,753,376 granted on 2023-09-12Benzyloxy pyridine derivatives and uses thereof
#7 | 2021-11-11 ✅ Patent 11,981,618 granted on 2024-05-14P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same
#8 | 2021-09-30 ✅ Patent 12,129,218 granted on 2024-10-29AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same
#9 | 2021-06-03 ✅ Patent 12,427,346 granted on 2025-09-30NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME
Also check out AUTOTAC INC.'s (Seoul, South Korea) applicant profile with 8 patent applications submitted.
328555 ⎘